What Should Pharmacists Know about the 2026 Dyslipidemia Guidelines

This activity will detail the important updates within the 2026 Dyslipidemia Guideline, which replaced the 2018 Cholesterol Guideline. Pharmacists provide crucial services for patients with elevated blood cholesterol, especially those at risk for, and with atherosclerotic cardiovascular disease (ASCVD). This activity will highlight the important updates which are crucial for pharmacists to know in the context of ASCVD surveillance and treatment.